96 results on '"Sze D"'
Search Results
2. Abstract No. 79 Comparison of 90Y Radioembolization Outcomes for Hepatocellular Carcinoma (HCC) in TACE-Refractory (T-REF) vs Treatment Naïve (TN) Patients in the RESiN Registry (NCT: 02685631)
3. Abstract No. 130 Comparing Survival Outcomes and Toxicities of 90Y Radioembolization of Colorectal Cancer Metastatic to the Liver Between Patients Older and Younger than 70: Analysis from the RESiN Registry (NCT02685631)
4. Abstract No. 272 Selective Hepatic Vein Sampling for Enriched Circulating Tumor Cell Collection in Patients with Liver Dominant Malignancy—Preliminary Results
5. Abstract No. 80 Progression and Survival Outcomes of Hepatocellular Carcinoma (HCC) Patients within Milan Criteria Following 90Y Radioembolization Using the Radiation-Emitting SIR-Spheres in Non-Resectable Tumor (RESiN) Registry NCT 02685631
6. Abstract No. 1 ▪ ABSTRACT OF THE YEAR Survival outcomes and toxicities following Y-90 radioembolization of colorectal cancer metastatic to the liver: 498-patient analysis from the RESiN registry (NCT: 02685631)
7. Abstract No. 304 Evaluation of survival and toxicity of cholangiocarcinoma treated with Y-90 radioembolization: outcomes assessment from the radiation emitting SIR-Spheres in non-resectable tumor registry
8. Abstract No. 196 Overall survival and toxicities of advanced hepatocellular carcinoma (HCC) Barcelona clinic liver cancer C (BCLC-C) patients following Y-90 radioembolization: assessment from the RESiN Registry (NCT: 02685631)
9. Abstract No. 553 Hypervascularity of hepatic metastases from colon cancer is underestimated by computed tomography or magnetic resonance imaging but does not influence outcomes of Y90 radioembolization
10. 3:45 PM Abstract No. 27 Neutrophil-lymphocyte ratio correlates with survival in MUlticenter Study of RAS Mutations (MURAS) in patients with colorectal liver metastases receiving Y90 radioembolization treatment
11. 3:54 PM Abstract No. 114 Percutaneous treatment of renal transplant ureteral strictures using multiple parallel ureteral stents
12. Abstract No. 481 Impact of the Introduction to Research Online Program (ITROP) on IR-bound trainees
13. Abstract No. 448 Bronchial artery embolization for hemoptysis in cystic fibrosis patients
14. 03:36 PM Abstract No. 348 Gender awareness in leadership promotes more diverse speaker representation
15. 03:18 PM Abstract No. 270 Parallel TIPS versus DIPS for second percutaneous portosystemic shunt placement in cirrhotic patients with an existing TIPS
16. 03:36 PM Abstract No. 97 The Wallflex colonic stent adapted for endovascular treatment of malignant IVC obstruction
17. Abstract No. 115 Demographics and outcomes following Y90 radioembolization of hepatocellular carcinoma at transplant versus non-transplant centers: analysis of the radiation-emitting SIR-spheres in non-resectable liver tumor (RESiN) registry
18. 4:12 PM Abstract No. 369 Tumor progression and resection candidacy after portal vein embolization
19. 3:54 PM Abstract No. 357 Venous stenting above versus below the inguinal ligament: 20-year experience
20. 3:36 PM Abstract No. 125 Single-day outpatient yttrium-90 radioembolization using resin microspheres
21. 3:09 PM Abstract No. 122 Lobar or whole-liver Yttrium-90 radioembolization using resin microspheres without prophylactic embolization of the gastroduodenal artery
22. 3:36 PM Abstract No. 145 Quantification of activity lost to delivery-system residual and decay in Yttrium-90 radioembolization
23. 3:27 PM Abstract No. 124 MIRD-based activity calculation may improve outcomes over body surface area for resin microsphere radioembolization of metastatic colorectal carcinoma
24. Abstract No. 516 Treatment of parasitized gastric arteries supplying hepatic tumors
25. 4:12 PM Abstract No. 119 Are transjugular intrahepatic portosystemic shunts (TIPSs) effective and durable in pediatric patients?
26. 4:03 PM Abstract No. 88 Retrospective analysis of second-line Y-90 compared to 1st line Y-90 in patients with nonresectable hepatocellular carcinoma
27. 3:36 PM Abstract No. 365 Bifurcated Y-stent placement for treatment of superior vena cava syndrome involving both brachiocephalic veins and superior vena cava
28. Does the location of bleeding varices affect rebleeding risk after transjugular intrahepatic portosystemic shunt placement?
29. Clinical toxicity of irinotecan-eluting microsphere TACE for colorectal cancer hepatic metastases: oncozene versus LC bead
30. Hepatic abscess after transarterial chemoembolization (TACE): a complication with possible therapeutic effect via serendipitous immunotherapy
31. Persistence of varices on CT or MR imaging and risk of variceal hemorrhage after transjugular intrahepatic portosystemic shunt with embolotherapy
32. No difference in postprocedure complications and reintervention after direct intrahepatic portocaval shunts versus transjugular intrahepatic portosystemic shunts
33. Outcomes of varix embolization and sclerosis in patients undergoing transjugular intrahepatic portosystemic shunt placement for refractory ascites
34. Effect of embolization or sclerosis on variceal hemorrhage after transjugular intrahepatic portosystemic shunt placement
35. Selection between locoregional embolotherapies for hepatic metastases from neuroendocrine tumor: Stratification by tumor burden
36. Persistent variceal filling on portal venography after transjugular intrahepatic portosystemic shunt creation and the risk of post-TIPS variceal hemorrhage
37. Clinical outcomes after parallel TIPS and DIPS using stent-grafts
38. Drug eluting bead chemoembolization for neuroendocrine tumor metastases: risk factors for biliary toxicity
39. Embolotherapy for neuroendocrine tumor liver metastases: prognostic factors for hepatic progression-free survival and overall survival
40. Yttrium-90 radioembolization for unresectable combined hepatocellular-cholangiocarcinoma
41. Yttrium-90 radioembolization of extrahepatic nodal metastases
42. Educational exhibit: bronchial artery embolization: an algorithm for management of hemoptysis in cystic fibrosis patients based on 15 year institutional experience
43. Yttrium-90 radioembolization using resin microspheres without prophylactic embolization of the gastroduodenal artery
44. Off-label intravascular uses of embolic glue: how we avoid sticky situations
45. The use of transcatheter selective arterial chemoembolization in pediatric patients with unresectable hepatocellular carcinoma
46. Accuracy of estimates of treated volume from C-arm cone-beam computed tomography data during partial splenic embolization using N-butyl cyanoacrylate
47. Use of endovascular stents for management of pediatric May-Thurner syndrome: a single-center experience
48. Twenty years of lower extremity venous stenting experience
49. Abstract No. 546 - No difference in postprocedure complications and reintervention after direct intrahepatic portocaval shunts versus transjugular intrahepatic portosystemic shunts
50. Abstract No. 483 - Drug eluting bead chemoembolization for neuroendocrine tumor metastases: risk factors for biliary toxicity
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.